NCT04628780 Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors Status TERMINATED Phase PHASE1
NCT04623502 An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy Status RECRUITING Phase NA
NCT04609800 Study on the Utilization of Cabozantinib in Adult Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC) in 2nd Line Treatment Following Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Therapy Under Real-real Life Clinical Setting in France. Status WITHDRAWN Phase N/A
NCT04609293 Observational Study of Camrelizumab Combined With Apatinib and Hyperfractionated Radiotherapy for Renal Cell Carcinoma Status UNKNOWN Phase N/A
NCT04601129 Advantage of a Fast-recovery Protocol for Minimally Invasive Kidney Surgery Status COMPLETED Phase N/A
NCT04596033 TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy Status TERMINATED Phase PHASE1
NCT04580836 MRI-Guided Radiation Therapy for the Treatment of Early-Stage Kidney Cancer, the MRI-MARK Trial Status WITHDRAWN Phase PHASE2
NCT04570176 Efficacy and Safety of Clinical Telesurgery Using Chinese Independently Developed Surgical Robot System Status COMPLETED Phase NA
NCT04540705 A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread Status COMPLETED Phase PHASE1
NCT04535687 Fluzoparib in Patients With Metastatic Non-clear Cell Renal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT04495894 Pre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell Carcinoma Status TERMINATED Phase PHASE2
NCT04495257 A Study of APX005M in Combination With Nivolumab and Ipilimumab in Treatment Naïve Patients With Advanced Melanoma or Renal Cell Carcinoma (RCC) Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04440943 A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT04438083 A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma (COBALT-RCC) Status TERMINATED Phase PHASE1